Everence Capital Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.54M | Hold |
12,030
| – | – | 0.16% | 117 |
|
|
2025
Q4 | $2.47M | Hold |
12,030
| – | – | 0.15% | 119 |
|
|
2025
Q3 | $1.89M | Hold |
12,030
| – | – | 0.11% | 148 |
|
|
2025
Q2 | $2.02M | Hold |
12,030
| – | – | 0.13% | 136 |
|
|
2025
Q1 | $1.66M | Hold |
12,030
| – | – | 0.11% | 162 |
|
|
2024
Q4 | $1.42M | Buy |
12,030
+1,940
| +19% | +$226K | 0.09% | 178 |
|
|
2024
Q3 | $1.11M | Sell |
10,090
-3,850
| -28% | -$403K | 0.07% | 215 |
|
|
2024
Q2 | $1.44K | Hold |
13,940
| – | – | 0.1% | 175 |
|
|
2024
Q1 | $1.56K | Hold |
13,940
| – | – | 0.1% | 175 |
|
|
2023
Q4 | $1.41M | Buy |
13,940
+3,030
| +28% | +$301K | 0.1% | 185 |
|
|
2023
Q3 | $947 | Sell |
10,910
-3,330
| -23% | -$301K | 0.07% | 222 |
|
|
2023
Q2 | $1.17M | Hold |
14,240
| – | – | 0.1% | 179 |
|
|
2023
Q1 | $1.07K | Sell |
14,240
-6,810
| -32% | -$514K | 0.09% | 201 |
|
|
2022
Q4 | $1.62K | Buy |
21,050
+2,730
| +15% | +$207K | 0.14% | 137 |
|
|
2022
Q3 | $1.22M | Buy |
18,320
+6,400
| +54% | +$406K | 0.11% | 158 |
|
|
2022
Q2 | $623K | Hold |
11,920
| – | – | 0.06% | 275 |
|
|
2022
Q1 | $676K | Hold |
11,920
| – | – | 0.05% | 295 |
|
|
2021
Q4 | $614K | Sell |
11,920
-8,350
| -41% | -$410K | 0.05% | 345 |
|
|
2021
Q3 | $1M | Buy |
20,270
+7,650
| +61% | +$415K | 0.08% | 201 |
|
|
2021
Q2 | $720K | Hold |
12,620
| – | – | 0.06% | 272 |
|
|
2021
Q1 | $767K | Hold |
12,620
| – | – | 0.07% | 229 |
|
|
2020
Q4 | $676K | Hold |
12,620
| – | – | 0.07% | 250 |
|
|
2020
Q3 | $593K | Buy |
12,620
+4,450
| +54% | +$228K | 0.07% | 248 |
|
|
2020
Q2 | $447K | Hold |
8,170
| – | – | 0.05% | 331 |
|
|
2020
Q1 | $392K | Hold |
8,170
| – | – | 0.06% | 304 |
|
|
2019
Q4 | $413K | Hold |
8,170
| – | – | 0.06% | 350 |
|
|
2019
Q3 | $386K | Hold |
8,170
| – | – | 0.06% | 340 |
|
|
2019
Q2 | $385K | Hold |
8,170
| – | – | 0.06% | 342 |
|
|
2019
Q1 | $393K | Hold |
8,170
| – | – | 0.07% | 321 |
|
|
2018
Q4 | $364K | Hold |
8,170
| – | – | 0.08% | 249 |
|
|
2018
Q3 | $441K | Hold |
8,170
| – | – | 0.09% | 246 |
|
|
2018
Q2 | $399K | Hold |
8,170
| – | – | 0.08% | 259 |
|
|
2018
Q1 | $512K | Hold |
8,170
| – | – | 0.11% | 213 |
|
|
2017
Q4 | $501K | Hold |
8,170
| – | – | 0.11% | 216 |
|
|
2017
Q3 | $547K | Hold |
8,170
| – | – | 0.12% | 213 |
|
|
2017
Q2 | $637K | Hold |
8,170
| – | – | 0.16% | 179 |
|
|
2017
Q1 | $666K | Hold |
8,170
| – | – | 0.17% | 164 |
|
|
2016
Q4 | $588K | Hold |
8,170
| – | – | 0.17% | 168 |
|
|
2016
Q3 | $635K | Hold |
8,170
| – | – | 0.19% | 151 |
|
|
2016
Q2 | $637K | Buy |
8,170
+3,620
| +80% | +$289K | 0.2% | 145 |
|
|
2016
Q1 | $373K | Hold |
4,550
| – | – | 0.12% | 216 |
|
|
2015
Q4 | $406K | Hold |
4,550
| – | – | 0.13% | 203 |
|
|
2015
Q3 | $350K | Hold |
4,550
| – | – | 0.12% | 214 |
|
|
2015
Q2 | $381K | Hold |
4,550
| – | – | 0.12% | 210 |
|
|
2015
Q1 | $400K | Buy |
4,550
+1,520
| +50% | +$131K | 0.13% | 203 |
|
|
2014
Q4 | $245K | Buy |
+3,030
| New | +$239K | 0.08% | 252 |
|
Other funds holding CAH
VCM
VPM
Everence Capital Management's CAH Position: Q1 2026 in Review
Everence Capital Management held its Cardinal Health (CAH) position steady in Q1 2026 at 12,030 shares worth $2.54M. The position accounts for 0.16% of the portfolio, ranked #117.
Everence Capital Management first reported a position in CAH in Q4 2014 and has held it in 46 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Everence Capital Management held 12,030 shares of Cardinal Health worth $2.54M as of Q1 2026.
- Everence Capital Management left its Cardinal Health share count unchanged in Q1 2026.
- Cardinal Health made up 0.16% of Everence Capital Management's portfolio in Q1 2026, its #117 holding.
- Everence Capital Management first reported a position in Cardinal Health in Q4 2014 and has held it in 46 quarters since.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.